Sepsis-induced cardiomyopathy

1 paper1 finding

Humans1

Associations

1

GLP-1 receptor agonists

downin humans1HR 0.82

1 study

GLP-1 receptor agonists lower the risk of sepsis-induced cardiomyopathy in humans (HR 0.82, 95% CI 0.78-0.87).
Humansin adults with type 2 diabetes mellitus and infection1 year
Antecedent glucagon-like peptide-1 receptor agonist use and risk of sepsis-induced cardiomyopathy in type 2 diabetes: a United States real-world active-comparator cohort study
Frontiers in pharmacology31 Jul 2026

More on GLP-1 receptor agonists

Latest

1 in 12 months

Frontiers in Pharmacology15 Aug

Antecedent glucagon-like peptide-1 receptor agonist use and risk of sepsis-induced cardiomyopathy in type 2 diabetes: a United States real-world active-comparator cohort study

Cohort study of 189,156 peopleCardiomyopathy